M. Grabe, M. Bishop, T. Bjerklund-johansen, H. Botto, M. Çek et al., EAU guidelines for the management of urinary and male genital tract infections. Urinary Tract Infection (UTI) Working Group of the Health Care Office (HCO) of the European Association of Urology (EAU). Arnhem, The Netherlands: EAU, 2006.

G. Kahlmeter, An international survey of the antimicrobial susceptibility of pathogens from uncomplicated urinary tract infections: the ECOmiddle dotSENS Project, Journal of Antimicrobial Chemotherapy, vol.51, issue.1, pp.69-76, 2003.
DOI : 10.1093/jac/dkg028

T. Hooton, R. Besser, B. Foxman, T. Fritsche, and L. Nicolle, Acute Uncomplicated Cystitis in an Era of Increasing Antibiotic Resistance: A Proposed Approach to Empirical Therapy, Clinical Infectious Diseases, vol.39, issue.1
DOI : 10.1086/422145

R. Raz, B. Chazan, Y. Kennes, R. Colodner, E. Rottensterich et al., Empiric Use of Trimethoprim???Sulfamethoxazole (TMP???SMX) in the Treatment of Women with Uncomplicated Urinary Tract Infections, in a Geographical Area with a High Prevalence of TMP???SMX???Resistant Uropathogens, Clinical Infectious Diseases, vol.34, issue.9, pp.1165-1174, 2002.
DOI : 10.1086/339812

K. Naber, G. Schito, H. Botto, J. Palou, and T. Mazzei, Surveillance Study in Europe and Brazil on Clinical Aspects and Antimicrobial Resistance Epidemiology in Females with Cystitis (ARESC): Implications for Empiric Therapy, European Urology, vol.54, issue.5, pp.1164-78, 2008.
DOI : 10.1016/j.eururo.2008.05.010

R. Rubin, E. Shapiro, V. Andriole, R. Davis, and W. Stamm, Evaluation of New Anti-Infective Drugs for the Treatment of Urinary Tract Infection, Clinical Infectious Diseases, vol.15, issue.Supplement 1, pp.216-243, 1992.
DOI : 10.1093/clind/15.Supplement_1.S216

C. Mugnaioli, F. Luzzaro, D. Luca, F. Brigante, G. Perilli et al., CTX-M-Type Extended-Spectrum ??-Lactamases in Italy: Molecular Epidemiology of an Emerging Countrywide Problem, Antimicrobial Agents and Chemotherapy, vol.50, issue.8, pp.2700-2706, 2006.
DOI : 10.1128/AAC.00068-06

K. Naber, B. Bergman, M. Bishop, T. Bjerklund-johansen, H. Botto et al., EAU Guidelines for the Management of Urinary and Male Genital Tract Infections<sup>1</sup>, European Urology, vol.40, issue.5, pp.576-88, 2001.
DOI : 10.1159/000049840

G. Kahlmeter, Prevalence and antimicrobial susceptibility of pathogens in uncomplicated cystitis in Europe. The ECOaSENS study, International Journal of Antimicrobial Agents, vol.22, issue.2, pp.49-52, 2003.
DOI : 10.1016/S0924-8579(03)00229-2

R. Raz, R. Colodner, and C. Kunin, Who Are You--Staphylococcus saprophyticus?, Clinical Infectious Diseases, vol.40, issue.6, pp.896-904, 2005.
DOI : 10.1086/428353

G. Fadda, G. Nicoletti, G. Schito, and G. Tempera, Antimicrobial Susceptibility Patterns of Contemporary Pathogens from Uncomplicated Urinary Tract Infections Isolated in a Multicenter Italian Survey: Possible Impact on Guidelines, Journal of Chemotherapy, vol.2003, issue.3, pp.251-258, 2005.
DOI : 10.1016/S0924-8579(02)00358-8

L. Stratchounski and V. Rafalski, Antimicrobial susceptibility of pathogens isolated from adult patients with uncomplicated community-acquired urinary tract infections in the Russian Federation: two multicentre studies, UTIAP-1 and UTIAP-2, International Journal of Antimicrobial Agents, vol.28, issue.1, pp.4-9, 2006.
DOI : 10.1016/j.ijantimicag.2006.05.015

S. Andrade, H. Sader, R. Jones, A. Pereira, A. Pignatari et al., Increased resistance to first-line agents among bacterial pathogens isolated from urinary tract infections in Latin America: time for local guidelines?, Mem??rias do Instituto Oswaldo Cruz, vol.101, issue.7, pp.741-749, 2006.
DOI : 10.1590/S0074-02762006000700006

J. Karlowsky, D. Hoban, M. Decorby, N. Laing, and G. Zhanel, Fluoroquinolone-Resistant Urinary Isolates of Escherichia coli from Outpatients Are Frequently Multidrug Resistant: Results from the North American Urinary Tract Infection Collaborative Alliance-Quinolone Resistance Study, Antimicrobial Agents and Chemotherapy, vol.50, issue.6, pp.2251-2255, 2006.
DOI : 10.1128/AAC.00123-06

R. Bonnet, Growing Group of Extended-Spectrum ??-Lactamases: the CTX-M Enzymes, Antimicrobial Agents and Chemotherapy, vol.48, issue.1, pp.1-14, 2004.
DOI : 10.1128/AAC.48.1.1-14.2004

R. Colodner, W. Rock, B. Chazan, N. Keller, N. Guy et al., Risk Factors for the Development of Extended-Spectrum Beta-Lactamase-Producing Bacteria in Nonhospitalized Patients, European Journal of Clinical Microbiology & Infectious Diseases, vol.23, issue.3, pp.163-170, 2004.
DOI : 10.1007/s10096-003-1084-2

H. Goossens, M. Ferech, V. Stichele, R. Elseviers, M. Esac-project et al., Outpatient antibiotic use in Europe and association with resistance: a cross-national database study, The Lancet, vol.365, issue.9459, pp.579-87, 2005.
DOI : 10.1016/S0140-6736(05)70799-6

G. Kahlmeter and P. Menday, Cross-resistance and associated resistance in 2478

P. Ho, R. Wong, K. Yip, S. Loke, M. Leung et al., Antimicrobial resistance in Escherichia coli outpatient urinary isolates from women: emerging multidrug resistance phenotypes, Diagnostic Microbiology and Infectious Disease, vol.59, issue.4, pp.439-484, 2007.
DOI : 10.1016/j.diagmicrobio.2007.06.012

D. Ungheri, E. Albini, and G. Belluco, to Fosfomycin Trometamol, Journal of Chemotherapy, vol.30, issue.3, pp.237-277, 2002.
DOI : 10.1007/BF01964433

S. Smith, A. Manges, and L. Riley, Temporal Changes in the Prevalence of Community-Acquired Antimicrobial-Resistant Urinary Tract Infection Affected by Escherichia coli Clonal Group Composition, Clinical Infectious Diseases, vol.46, issue.5, pp.689-95, 2008.
DOI : 10.1086/527386

A. Manges, J. Johnson, B. Foxman, O. Bryan, T. Fullerton et al., Clonal Group, New England Journal of Medicine, vol.345, issue.14, pp.1007-1020, 2001.
DOI : 10.1056/NEJMoa011265

G. Prats, F. Navarro, B. Mirelis, D. Dalmau, N. Margall et al., Escherichia coli serotype O15:K52:H1 as a uropathogenic clone, J Clin Microbiol, vol.38, pp.201-210, 2000.

M. Nicolas-chanoine, J. Blanco, V. Leflon-guibout, R. Demarty, M. Alonso et al., Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15, Journal of Antimicrobial Chemotherapy, vol.61, issue.2, pp.273-81, 2008.
DOI : 10.1093/jac/dkm464

URL : https://hal.archives-ouvertes.fr/inserm-00258588

S. Cagnacci, L. Gualco, E. Debbia, G. Schito, and A. Marchese, European Emergence of Ciprofloxacin-Resistant Escherichia coli Clonal Groups O25:H4-ST 131 and O15:K52:H1 Causing Community-Acquired Uncomplicated Cystitis, Journal of Clinical Microbiology, vol.46, issue.8, pp.2605-2617, 2008.
DOI : 10.1128/JCM.00640-08